CTOS 2021

Connective Tissue Oncology Society Annual Meeting 2021

The virtual annual CTOS meeting will bring together specialized physicians, medical professionals, and scientists from around the world to share and discuss the latest topics on multi-disciplinary sarcoma science and clinical practice.


At the virtual meeting, Boehringer Ingelheim will be presenting findings on treatment for advanced/metastatic sarcoma.

Wednesday 10 November – Saturday 13 November 2021
Virtual format
Friday, 12 November 2021
A Phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients with advanced/metastatic sarcoma
Author(s): Gounder et al.
Oral Presentation
Tumor Type(s): sarcoma
Presentation Number: 44
There are no publications which meet your criteria on this date

Find out more about other oncology events

Click here to find out more about other oncology meetings, congresses, symposia and activities sponsored by Boehringer Ingelheim.

Pipeline compounds shown here are under preclinical and/or clinical investigation, and have not been approved. Their safety and efficacy have not been established.


© 2021 Boehringer Ingelheim International GmbH. All rights reserved.


Page last updated: November 2021